| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addition of aerobic physical activity to resistance exercise for hip osteoarthritis (PHOENIX): a randomised comparative effectiveness trial
|
Hall, Michelle
|
|
|
7 |
5 |
p. e343-e354
|
artikel
|
| 2 |
Addressing evidence gaps in exercise for hip osteoarthritis
|
Kjeldsen, Troels
|
|
|
7 |
5 |
p. e308-e310
|
artikel
|
| 3 |
Biological disease-modification in axial spondyloarthritis: insights from MRI
|
Diekhoff, Torsten
|
|
|
7 |
5 |
p. e304-e305
|
artikel
|
| 4 |
Correction to Lancet Rheumatol 2020; 2: e418–27
|
|
|
|
7 |
5 |
p. e311
|
artikel
|
| 5 |
Correction to Lancet Rheumatol 2020; 2: e99–109
|
|
|
|
7 |
5 |
p. e311
|
artikel
|
| 6 |
Correction to Lancet Rheumatol 2025; published online Feb 27. https://doi.org/10.1016/S2665-9913(24)00348-5
|
|
|
|
7 |
5 |
p. e311
|
artikel
|
| 7 |
Diagnostic, research, and real-life effect of the 2023 EULAR−ACR classification criteria for antiphospholipid syndrome
|
Schreiber, Karen
|
|
|
7 |
5 |
p. e368-e376
|
artikel
|
| 8 |
Evolution and trajectory of B-cell targeted therapies in rheumatic diseases
|
Carter, Lucy Marie
|
|
|
7 |
5 |
p. e355-e367
|
artikel
|
| 9 |
Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trial
|
Fretheim, Håvard
|
|
|
7 |
5 |
p. e323-e332
|
artikel
|
| 10 |
Is faecal microbiota transplantation ready for prime time in systemic sclerosis?
|
Tay, Shu Wen
|
|
|
7 |
5 |
p. e305-e307
|
artikel
|
| 11 |
Laura Coates: all about the people
|
Van Epps, Heather
|
|
|
7 |
5 |
p. e313
|
artikel
|
| 12 |
Research in Brief
|
Thorley, Jennifer
|
|
|
7 |
5 |
p. e312
|
artikel
|
| 13 |
Survival in patients with rheumatoid arthritis and recently diagnosed early-stage colorectal, lung, or prostate cancer receiving tumour necrosis factor inhibitors: a retrospective cohort study
|
Ruiz, Juan I
|
|
|
7 |
5 |
p. e333-e342
|
artikel
|
| 14 |
Targeting the most vulnerable—a step too far
|
The Lancet Rheumatology,
|
|
|
7 |
5 |
p. e303
|
artikel
|
| 15 |
The effect of ixekizumab treatment on MRI sacroiliac joint structural lesions in patients with radiographic axial spondyloarthritis: post-hoc analysis of a 52-week, randomised, placebo-controlled trial with an active reference arm
|
Maksymowych, Walter P
|
|
|
7 |
5 |
p. e314-e322
|
artikel
|
| 16 |
Tumour necrosis factor inhibitor safety in rheumatoid arthritis with early-stage cancer
|
Sparks, Jeffrey A
|
|
|
7 |
5 |
p. e307-e308
|
artikel
|
Tijdschrift beschrijving